Anatomical Evaluation of Supraspinatus Through Ultrasonography and Biomechanical Measurements Following Different Combinations of Physical Therapies in Patients of Supraspinatus Tendinitis

March 9, 2026 updated by: Sehat Medical Complex
A randomized controlled trial will be conducted to get the expected outcomes. Patients of both gender groups with unilateral shoulder pain will be selected with age range 40-60 years from Sehat medical complex and randomly allocated into four groups (Group A, B, C and D) of two different trials (Trial I and Trial II). The sample size will be 120 patients for both trials. Musculoskeletal ultrasound, goniometry, pain pressure threshold, dynamometer and functional indices will be used to measure the tendon thickness, range of motion, pain, muscle strength and function level. The group A will get BFRT, Group B will get ESWT, group c will get the combination of both and group D will be the Control group (Routine physical therapy). In Trial II the group A will get BFRT, Group B will get Eccentric Training, Group C will get combination of both A & B and group D will be control group. data will be collected at baseline, 4th week, 8th week and 12 week of interventions. For data analysis SPSS version 25 will be used. Repeated measures ANOVA will be applied to compare the quantitative data within and between the groups. Post-Hoc test Tukey and Bonferroni correction will be used. The level of significance will be set at 5% (P<0.05).

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Musculoskeletal (MSK) disorders affect 1.71 billion people globally. In Pakistan 3.7-20% people are suffering from shoulder pain and while other rotator cuff muscles have been targeted with various therapies singly, neither supraspinatus tendinitis has received its due attention nor has the effect of combination of therapies been explored on it. Additionally, using the technique of MSK ultrasound will give us an objective quantitative basis for the anatomical evaluation. The tendon dimensions and biomechanical measurements of the supraspinatus show marked and differential improvement under the influence of different combinations of physical therapies compared to any single therapy.

Objectives:

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Sahar Ijaz, PhD Anatomy

Study Locations

  • Pakistan
    • Punjab Province
      • Lahore, Punjab Province, Pakistan, 54000
        • Recruiting
        • Sehat Medical Complex/UOL/UVAS
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • unilateral shoulder pain
  • both gender group
  • two positive tests of (Neer impingement test, Hawkins-Kendy test, Empty can test),
  • shoulder pain history up to 3 months
  • not receiving any physiotherapy last 3 months.
  • not receiving pain medications (NSAIDS) for last 15 days.

Exclusion Criteria:

  • referred shoulder pain
  • limited shoulder ROM less then 90 degree
  • previous shoulder surgery, intra articular injection or nerve block last 6 months.
  • patient with 180 mmHg blood pressure/uncontrolled BP
  • upper limb fracture, uncontrolled diabetes, open wounds, fistula and vascular surgery.
  • pregnant woman or 6 month history of pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group A (Blood Flow Restriction Therapy)
4 Sets of exercise with restriction cuff 30,15,15,15 with cable system pulley
Other: Blood flow Restriction therapy
BFRT 4 Sets of exercise with restriction cuff 30,15,15,15 with cable system pulley ESWT 10 minutes shocks of 2000 J/session
Other Names:
  • ESWT
  • BFRT
Experimental: Group B (Extracorporeal Shock wave therapy)
10 minutes shocks of 2000 J/session
Device: ESWT
10 minutes shocks of 2000 J/session
Other Names:
  • Shock wave therapy
Experimental: Group C (Combination of BFRT+ESWT)
Interventional study group Combination therapy
Other: Blood flow Restriction therapy
BFRT 4 Sets of exercise with restriction cuff 30,15,15,15 with cable system pulley ESWT 10 minutes shocks of 2000 J/session
Other Names:
  • ESWT
  • BFRT
Device: ESWT
10 minutes shocks of 2000 J/session
Other Names:
  • Shock wave therapy
Sham Comparator: Control Group D
Control group with routine physical therapy
Other: Control
Electric heating pad (Besmed, Taiwan) 10 minutes, TENS (Comfy Stim, Taiwan Model #: EV-806) 10 minutes
Other Names:
  • Routine physical therapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Shoulder Joint Range of Motion from 0-180 degree
Time Frame: 12 weeks
shoulder joint ROM will be measured by Goniometer having 360 degree or inclinometer
12 weeks
MSK Ultrasound for shoulder
Time Frame: 12 weeks
tendon thickness in long (mm) and short axis (mm)
12 weeks
Shoulder Functional scale
Time Frame: 12 weeks
Quick-DASH (Quick-Disability of arm shoulder and hand) functional scale, it is 11 items scale with response range 0-5 on. 0 is no disability and 100 shows severe disability. The scale have 5 response options much worse, somewhat worse, unchanged, somewhat better, much better
12 weeks
Shoulder Joint PAIN
Time Frame: 12 WEEKS
NPRS 0-10 , 10 is the worse imaginable pain and 0 is no pain
12 WEEKS
Shoulder Muscle Strength
Time Frame: 12 weeks
Manual muscle testing and Dynamometer
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sehat Medical Complex

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 23, 2026

Primary Completion (Estimated)

August 23, 2026

Study Completion (Estimated)

August 30, 2026

Study Registration Dates

First Submitted

February 25, 2026

First Submitted That Met QC Criteria

March 9, 2026

First Posted (Actual)

March 13, 2026

Study Record Updates

Last Update Posted (Actual)

March 13, 2026

Last Update Submitted That Met QC Criteria

March 9, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 434/IRC/BMR/DATED:30/12/2025

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

the study protocol

IPD Sharing Time Frame

12 weeks till the trail is recutting

IPD Sharing Access Criteria

by email, any researcher

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Supraspinatus Tendinitis

Clinical Trials on Blood flow Restriction therapy

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Canada

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe